Pulmonary defense against aspergillus fumigatus
Pulmonary defense against aspergillus fumigatus
批准号:
8258356
负责人:
Chad Steele
金额:
$40.46万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2014-04-30
关键词:
AddressAffectAlveolar MacrophagesAntifungal AgentsAscaridilAspergillosisAspergillus fumigatusAttenuatedCCL2 geneCCR6 geneCXCL12 geneCXCR4 geneCellsDataDefectDevelopmentFamily memberGenerationsHost DefenseIRF4 geneITGAM geneITGAX geneImmune responseImmunityImmunocompromised HostIn VitroIndividualInfectionInflammatoryInflammatory ResponseInterleukin-17Interleukin-6LungLymphoidMaintenanceMediatingMediator of activation proteinMissionMoldsMusMycosesMyelogenousMyeloid CellsNatural ImmunityPathway interactionsPattern recognition receptorPopulationPredispositionProductionReactionReporterReportingResistanceRoleSTAT3 geneShapesSignal TransductionSourceStaining methodStainsStromal Cell-Derived Factor 1TestingWorkbeta-glucan receptorchemokinechemokine receptorcytokinedectin 1in vivoinnovationinterleukin-22interleukin-23neutralizing antibodyneutrophilpublic health relevanceresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Invasive pulmonary aspergillosis caused by the mold Aspergillus fumigatus has emerged as one of the most severe invasive fungal infections, not only in an expanding population of immunosuppressed patients, but also in individuals who are not considered classically immunocompromised. Innate immunity against A. fumigatus involves an initial wave of inflammatory reaction by alveolar macrophages followed by the seek-and- destroy mission of neutrophils. We have previously shown that the beta-glucan receptor Dectin-1 mediates alveolar macrophage (AM) inflammatory responses to A. fumigatus in vitro (Steele et al. PLoS Pathog 1:e42 Dec. 2005) and since the last review of this proposal (February 2009), we have now reported that mice deficient in Dectin-1 display an inherent susceptibility to A. fumigatus lung infection (Werner et al. J Immunol 182: 4938-4946, April 2009). A recent, intriguing finding was the observation that "innate IL-17" was a central component of resistance to A. fumigatus: (1) Dectin-1 KO mice had a defect in lung IL-17 production shortly after A. fumigatus challenge and (2) WT mice administered IL-17 neutralizing antibodies became susceptible to A. fumigatus infection. We now show by intracellular cytokine staining that the predominant cellular sources of IL-17 in the lungs after A. fumigatus challenge are surprisingly not lymphoid in origin, but rather myeloid CD11b+ and CD11c+ cell populations, which produce IL-17 in a Dectin-1 dependent manner. In other data, we show that IL-6 and TGF-¿, which are essential for the induction of Th17 cells, are not produced at lower levels in the lungs of Dectin-1 KO mice exposed to A. fumigatus, suggesting that other mechanisms/mediators are responsible for Dectin-1 dependent IL-17 production. In turn, new data indicate that production of the Th17/IL- 17 induction cytokine IL-21 and the Th17/IL-17 maintenance cytokine IL-23 are attenuated in Dectin-1 KO mice after A. fumigatus challenge, as are the chemokines CXCL12/SDF-1 and CCL2/MCP-1. These results suggest that Dectin-1 may control IL-17 levels in the lungs after A. fumigatus exposure via production of IL-17- associated induction cytokines or production of chemokines essential for the recruitment of IL-17-producing cells to the lungs. Finally, the Th17/IL-17 associated cytokine IL-22 was found to be highly dependent in Dectin-1 for its expression in the lungs. Therefore, we hypothesize that optimal IL-17-mediated defense against A. fumigatus is dependent on the beta glucan receptor Dectin-1. The following Specific Aims will test our hypothesis: (1) To identify the Dectin-1 dependent cellular source of IL-17 in the lungs after A. fumigatus exposure, (2) To identify the mechanism(s) responsible for Dectin-1 dependent, cell-specific production of IL-17 after A. fumigatus lung exposure and (3) To determine whether mediators associated with IL-17 induction (IL-21/IL-23), recruitment (SDF-1/MCP-1) and signaling (IL-22) pathways modulate lung host defense against A. fumigatus.
PUBLIC HEALTH RELEVANCE: Our data indicate that the Dectin-1 beta-glucan receptor is essential for immunity against Aspergillus fumigatus, the etiological agent of invasive pulmonary aspergillosis, by controlling an "innate IL-17" pathway that may be ultimately required for clearance of A. fumigatus from the lungs. Studies in this proposal will further characterize the cellular source of innate IL-17, the Dectin-1 dependent mechanisms for the generation of this cell population and whether IL-17 family members can modulate host defense against A. fumigatus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of innate IL-22 during lung fungal infection
-
批准号:10643901
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2017
-
负责人:Chad Steele
-
依托单位:
Biology of innate IL-22 during lung fungal infection
-
批准号:10316508
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2017
-
负责人:Chad Steele
-
依托单位:
Biology of innate IL-22 during lung fungal infection
-
批准号:10474632
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2017
-
负责人:Chad Steele
-
依托单位:
Immunopathogenesis in fungal asthma
-
批准号:10580779
-
项目类别:
-
资助金额:$49.06万
-
财政年份:2014
-
负责人:Chad Steele
-
依托单位:
Immunopathogenesis in fungal asthma
-
批准号:8982244
-
项目类别:
-
资助金额:$43.58万
-
财政年份:2014
-
负责人:Chad Steele
-
依托单位:
Immunopathogenesis in fungal asthma
-
批准号:10356139
-
项目类别:
-
资助金额:$49.06万
-
财政年份:2014
-
负责人:Chad Steele
-
依托单位:
Immunopathogenesis in fungal asthma
-
批准号:9187993
-
项目类别:
-
资助金额:$43.11万
-
财政年份:2014
-
负责人:Chad Steele
-
依托单位:
Adaptive immunity against Pneumocystis
-
批准号:8616444
-
项目类别:
-
资助金额:$34.98万
-
财政年份:2013
-
负责人:Chad Steele
-
依托单位:
Adaptive immunity against Pneumocystis
-
批准号:8711554
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2013
-
负责人:Chad Steele
-
依托单位:
Adaptive immunity against Pneumocystis
-
批准号:8875748
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2013
-
负责人:Chad Steele
-
依托单位:
Eosinophils and lung immunity to Pneumocystis
-
批准号:8515522
-
项目类别:
-
资助金额:$17.43万
-
财政年份:2012
-
负责人:Chad Steele
-
依托单位:
Eosinophils and lung immunity to Pneumocystis
-
批准号:8419854
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2012
-
负责人:Chad Steele
-
依托单位:
STAT4 mediated immunity to Pneumocystis
-
批准号:8274651
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2011
-
负责人:Chad Steele
-
依托单位:
STAT4 mediated immunity to Pneumocystis
-
批准号:8164696
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2011
-
负责人:Chad Steele
-
依托单位:
Pulmonary defense against aspergillus fumigatus
-
批准号:7906440
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2010
-
负责人:Chad Steele
-
依托单位:
Pulmonary defense against aspergillus fumigatus
-
批准号:8194391
-
项目类别:
-
资助金额:$1.77万
-
财政年份:2010
-
负责人:Chad Steele
-
依托单位:
Pulmonary defense against aspergillus fumigatus
-
批准号:8461604
-
项目类别:
-
资助金额:$38.52万
-
财政年份:2010
-
负责人:Chad Steele
-
依托单位:
Pulmonary defense against aspergillus fumigatus
-
批准号:8066652
-
项目类别:
-
资助金额:$40.87万
-
财政年份:2010
-
负责人:Chad Steele
-
依托单位:
Dectin-1 and Invasive Pulmonary Aspergillosis
-
批准号:7591377
-
项目类别:
-
资助金额:$36.58万
-
财政年份:2009
-
负责人:Chad Steele
-
依托单位:
Dectin-1 and Invasive Pulmonary Aspergillosis
-
批准号:7876813
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2009
-
负责人:Chad Steele
-
依托单位:
海外基金